Sponsor or institution

Clinical trials and research at Groupe Francais De Pneumo-Cancerologie

• 6Clinical trials
• 1Country

Newest trials

All recruiting trials (6)

• Amivantamab with platinum chemotherapy for metastatic EGFR‑mutant non‑small cell lung cancer

  This study will try giving amivantamab together with platinum chemotherapy to adults with metastatic NSCLC who have specific EGFR mutations to see how long their cancer stays controlled and how safe the treatment is.

  Recruiting at 11 sites Groupe Francais De Pneumo-Cancerologie · Aix-en-Provence and 15 other locations · NCT07563205

• Long-term survivors of metastatic lung cancer: health, quality of life, and needs

  This project will follow people who have lived at least three years with metastatic lung cancer and are no longer on cytotoxic chemotherapy to see what their health, quality of life, and social needs are.

  Recruiting at 31 sites Groupe Francais De Pneumo-Cancerologie · Aix-en-Provence and 45 other locations · NCT07243132

• Evaluating treatments for elderly patients with lung cancer

  This study is trying to see how well different treatments work for older adults with lung cancer and how these treatments affect their quality of life.

  Recruiting at 33 sites Phase 4 Groupe Francais De Pneumo-Cancerologie · Aix-en-Provence and 40 other locations · NCT06646471

• Optimizing local ablative therapy with brigatinib for advanced ALK-positive lung cancer

  This study will test whether adding targeted local treatments to ongoing brigatinib helps people with advanced ALK-positive non-small cell lung cancer who have a limited number of remaining tumors.

  Recruiting at 3 sites Phase 2 Groupe Francais De Pneumo-Cancerologie · Brest and 26 other locations · NCT06620835

• Understanding resistance to amivantamab in lung cancer patients

  This study is trying to understand why some lung cancer patients with a specific mutation stop responding to the drug amivantamab, by looking at their blood and tumor samples after their disease gets worse.

  Recruiting at 10 sites Groupe Francais De Pneumo-Cancerologie · Bordeaux and 17 other locations · NCT06247826

• Analyzing biological characteristics of advanced ALK-rearranged lung cancer

  This study is trying to understand the biological features of advanced lung cancer with ALK gene changes in patients who are starting treatment with new targeted medications.

  Recruiting at 22 sites Groupe Francais De Pneumo-Cancerologie · Saint-Denis, La Réunion and 45 other locations · NCT05122806

Quick answers

How many clinical trials run by Groupe Francais De Pneumo-Cancerologie are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in France. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →